Peking University First Hospital
Beijing, China
Location status: Recruiting
NCT Number: NCT07144696
In this study, type 1 diabetes patients from the outpatient department of Peking University First Hospital were selected as the research objects. The investigators plan to recruit 150 participants. Using the course and teaching plan of "Take Control of My Life - Structured Education for Type 1 diabetes" issued by the China Type 1 diabetes Alliance, offline teaching is carried out regularly for type 1 diabetes patients, aiming to improve participants' knowledge and skills of disease self-management and improve participants' self-management behavior. The course content includes diabetes diet, exercise, blood glucose monitoring, insulin injection, complication prevention, psychological adjustment, etc. The training will take place at Peking University First Hospital. On the basis of structured courses, regular outpatient follow-up will be further carried out for patients to standardize their treatment behavior, improve their blood sugar compliance rate and delay the occurrence and development of diabetes complications. The subject visit is conducted on-site at the Endocrinology Clinic of Peking University First Hospital. The usual visit period is once every 1-3 months, and the specific follow-up time is determined by medical staff based on the subject's condition. Each visit lasts 1-3 hours, and each subject is expected to be followed up for 1 year. During each visit, collect the medical history and some personal information of the subjects, complete the routine physical examination, draw blood to test diabetes related indicators (including the determination of fasting and postprandial blood glucose, C-peptide, glycosylated hemoglobin, islet autoantibodies, blood lipids, liver and kidney functions), and screen diabetes complications. At the time of enrollment and after 1 year of follow-up, diabetes related questionnaires mainly related to diabetes self-management behavior and psychological emotions.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Beijing, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Regularly carry out structured diabetes courses for patients with type 1 diabetes and offline teaching at Peking University First Hospital. On the basis of structured courses, regular outpatient follow-up visits will be conducted for patients, with on-site visits conducted at the Endocrinology Clinic of Peking University First Hospital. The usual visit period is once every 1-3 months, and the specific follow-up time nodes will be determined by medical staff based on the patient's condition. Each visit will last 1-3 hours, and each subject is expected to be followed up for 1 year. During each visit, collect the medical history and some personal information of the subjects, complete the routine physical examination, draw blood to test diabetes related indicators (including the determination of fasting
Time frame: At baseline and 1-year follow-up
Glycated hemoglobin between 4%~6% is normal
Time frame: At baseline and 1-year follow-up
the minimum and maximum values is 0 and 120, and higher scores means better outcome
Time frame: At baseline and 1-year follow-up
the minimum and maximum values is 46 and 230, and higher scores means better outcome
Time frame: At baseline and 1-year follow-up
the minimum and maximum values is 0 and 40, 0-5 points means healthy,6-15 points means mild depressive,16-25 points means has symptoms of depression,26-40 points means severe or severe depressive symptoms
Contact information is provided by the study sponsor or research team.
Peking University First Hospital
Other
Study on the Improvement of Metabolic Indicators in Type 1 Diabetes Patients by Structured Education
Acronym: T1D
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06783309
Autoimmune Diseases, Diabetes Mellitus
Tucson, Arizona, United States
View Trial DetailsNCT07548996
Autoimmune Diseases, Diabetes Mellitus
Nanjing, Jiangsu, China
View Trial DetailsNCT07593625
Autoimmune Diseases, Diabetes (DM)
Christchurch, New Zealand
View Trial DetailsNCT07149142
Autoimmune Diseases, Cardiovascular Diseases
Prague, Prague 5, Czechia
View Trial Details